GLMP promotes EGFR-TKI resistance by activating autophagy and RhoA pathway in non-small cell lung cancer
Xiao Liang, Jiali Xu, Suhui Shu, Wei Lv, Dandan Yin, Sunan Miao, Xiyi Lu, Chen Zhang, Xinyin Liu, Jiali Dai, Jun Li, Weibing Wu, Erbao Zhang, Renhua Guo · 2025
Read GLMP promotes EGFR-TKI resistance by activating autophagy and RhoA pathway in non-small cell lung cancer by Xiao Liang, Jiali Xu, Suhui Shu, Wei Lv, Dandan Yin, Sunan Miao, Xiyi Lu, Chen Zhang, Xinyin Liu, Jiali Dai, Jun Li, Weibing Wu, Erbao Zhang, Renhua Guo (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12678831.txt.
Description
Resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) restricts the long-term efficacy of treatment in patients with lung cancer. Here, we report that the EGFR-TKI resistance mechanism is mediated by lysosome-related regulation. The overexpression of glycosylated lysosomal membrane protein (GLMP), a lysosomal membrane protein, promotes resistance to Osimertinib both in vitro and in vivo.
Catalog record
| CREATOR | Xiao Liang, Jiali Xu, Suhui Shu, Wei Lv, Dandan Yin, Sunan Miao, Xiyi Lu, Chen Zhang, Xinyin Liu, Jiali Dai, Jun Li, Weibing Wu, Erbao Zhang, Renhua Guo |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |